CAS 425399-05-9

Formel: C20H22N2O

InChl: InChI=1S/C20H22N2O/c23-12-11-21-19-8-4-7-16-17-13-15(14-5-2-1-3-6-14)9-10-18(17)22-20(16)19/h1-3,5-6,9-10,13,19,21-23H,4,7-8,11-12H2

InChI Key: RXIUMAOXORBRCY-UHFFFAOYSA-N

SMILES: C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)C4=CC=CC=C4)NCCO

CASIN

CAS: 425399-05-9

CASIN

Formel: C₂₀H₂₂N₂O

Reinheit: ≥98%

Molekulargewicht: 306.4

Ref: 54-BUP15074

CASIN

CAS: 425399-05-9

Formel: C₂₀H₂₂N₂O

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 306.4015

Ref: IN-DA00C6KZ

CASIN

CAS: 425399-05-9

CASIN (Pirl1-related Compound 2) is a specific inhibitor of GTPase Cdc42 (IC50: 2 uM).

Formel: C₂₀H₂₂N₂O

Reinheit: 98.18% - >99.99%

Farbe und Form: Solid

Molekulargewicht: 306.4015

Ref: TM-T3971

CASIN

CAS: 425399-05-9

2-((6-Phenyl-2,3,4,9-tetrahydro-1H-carbazol-1-yl)amino)ethan-1-ol

Formel: C₂₀H₂₂N₂O

Reinheit: 98%

Molekulargewicht: 306.4

Ref: IN-DG448324

CASIN

CAS: 425399-05-9

CASIN is a lysine-derived antimicrobial agent that inhibits the growth of bacteria by binding to the peptide chains of collagen, which are found in skin and mucous membranes. CASIN has been shown to inhibit the growth of many bacterial species, including those that are resistant to other antibiotics. CASIN can be used for the treatment of infectious diseases caused by bacteria, such as bacterial vaginosis or chlamydia. CASIN has also been shown to reduce body mass index in animal models. The mechanism of action is not known but may involve interference with an enzyme that controls the biosynthesis of fatty acids. The use of CASIN in humans is limited due to its toxicity on human cells and potential safety concerns.

Formel: C₂₀H₂₂N₂O

Reinheit: Min. 95%

Molekulargewicht: 306.4 g/mol

Ref: 3D-ASA39905